Spatiotemporal Dynamic of the RTS,S/AS01 Malaria Vaccine Target Antigens in Senegal

被引:1
|
作者
Diallo, Mamadou Alpha [1 ,2 ]
L'Ollivier, Coralie [3 ,4 ]
Diongue, Khadim [1 ,2 ]
Badiane, Aida Sadikh [1 ,2 ]
Kodio, Aly [3 ,4 ]
Tall, Mamadou Lamine [3 ]
Sy, Mouhamad [1 ,2 ]
Seck, Mame Cheikh [1 ,2 ]
Sene, Doudou [4 ]
Ndiaye, Mouhamadou [1 ,2 ]
Fall, Fatou Ba [5 ]
Ranque, Stephane [3 ,4 ]
Ndiaye, Daouda [1 ,2 ]
机构
[1] Cheikh Anta Diop Univ, Dept Parasitol & Mycol, Dakar, Senegal
[2] Aristide Le Dantec Univ Hosp, Dakar, Senegal
[3] Aix Marseille Univ, VITROME, SSA, AP HM,IRD, Marseille, France
[4] IHU Mediterranee Infect, Marseille, France
[5] Natl Malaria Control Program NMCP, Dakar, Senegal
来源
关键词
PLASMODIUM-FALCIPARUM; GENETIC DIVERSITY; CANDIDATE; EFFICACY; DIELMO;
D O I
10.4269/ajtmh.21-0369
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The RTS,S/AS01 malaria vaccine confers only moderate protection against malaria. Evidence suggests that the effectiveness of the RTS,S/AS01 vaccine depends upon the parasite population genetics, specifically regarding the circumsporozoite protein haplotypes in the population. We investigated Plasmodium falciparum circumsporozoite protein (PfCSP) gene sequences from two endemic sites in 2018 in Senegal. The PfCSP sequences were compared with those retrieved from the Pf3k genome database. In the central repeat region of PfCSP, the distribution of haplotypes differed significantly between the two study sites (Fisher's exact test, P , 0.001). No 3D7 vaccine strain haplotype was observed in this locus. In the C-terminal region, there was no significant difference in haplotypes distribution between Kedougou and Diourbel (Fischer's exact test, P 5 0.122). The 3D7 haplotype frequency was 8.4% in early samples (2001-2011), but then it contracted in the subsequent years. The extensive plasticity of the P. falciparum genes coding the RTS,S/AS01 vaccine target antigens may influence the immune responses to circulating alleles. Monitoring the genetic diversity baseline and its dynamics over time and space would be instrumental in rationally improving the malaria RTS,S/AS01 vaccine and/or its implementation schedule.
引用
收藏
页码:1738 / 1746
页数:9
相关论文
共 50 条
  • [1] Assessment of the RTS,S/AS01 malaria vaccine
    Moorthy, V. S.
    Newman, R. D.
    Duclos, P.
    Okwo-Bele, J. M.
    Smith, P. G.
    [J]. LANCET INFECTIOUS DISEASES, 2013, 13 (04): : 280 - 282
  • [2] RTS,S/AS01 malaria vaccine and child mortality
    Aaby, Peter
    Rodrigues, Amabelia
    Kofoed, Poul-Erik
    Benn, Christine Stabell
    [J]. LANCET, 2015, 386 (10005): : 1735 - 1736
  • [3] Implementation of the malaria candidate vaccine RTS,S/AS01
    Greenwood, Brian
    Doumbo, Ogobara K.
    [J]. LANCET, 2016, 387 (10016): : 318 - 319
  • [4] The history of the RTS,S/AS01 malaria vaccine trial
    Keating, Conrad
    [J]. LANCET, 2020, 395 (10233): : 1336 - 1337
  • [5] The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
    Juliette Fortpied
    Sylvie Collignon
    Nicolas Moniotte
    Frédéric Renaud
    Babak Bayat
    Dominique Lemoine
    [J]. Malaria Journal, 19
  • [6] The thermostability of the RTS,S/AS01 malaria vaccine can be increased by co-lyophilizing RTS,S and AS01
    Fortpied, Juliette
    Collignon, Sylvie
    Moniotte, Nicolas
    Renaud, Frederic
    Bayat, Babak
    Lemoine, Dominique
    [J]. MALARIA JOURNAL, 2020, 19 (01)
  • [7] RTS,S/AS01 Malaria Vaccine in African Children REPLY
    Hamel, Mary J.
    Abdulla, Salim
    Greenwood, Brian
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (08): : 765 - 766
  • [8] RTS,S/AS01 malaria vaccine-proven safe and effective?
    Bjorkman, Anders
    Benn, Christine Stabell
    Aaby, Peter
    Schapira, Allan
    [J]. LANCET INFECTIOUS DISEASES, 2023, 23 (08): : E318 - E322
  • [9] Implementation of RTS, S/AS01 Malaria Vaccine - The Need for Further Evidence
    Clemens, John
    Moorthy, Vasee
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 374 (26): : 2596 - 2597
  • [10] RTS,S/AS01 malaria vaccine (Mosquirix®): a profile of its use
    Yahiya Y. Syed
    [J]. Drugs & Therapy Perspectives, 2022, 38 : 373 - 381